Astrazeneca (AZN) Change in Acquisitions & Divestments (2009 - 2026)

Astrazeneca (AZN) has reported Change in Acquisitions & Divestments for 18 consecutive years, with -$85.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 8600.0% year-over-year to -$85.0 million; the TTM figure through Mar 2026 stood at $45.0 million (down 48.86% YoY), while the FY2025 annual figure was $131.0 million, up 336.67% from the prior year.
• Change in Acquisitions & Divestments came in at -$85.0 million for Q1 2026 at Astrazeneca, down from $9.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $114.0 million in Q2 2025, with the low at -$85.0 million in Q1 2026.
• Average Change in Acquisitions & Divestments over 5 years is $13.5 million, with a median of $9.0 million recorded in 2023.
• Across the five-year window, Change in Acquisitions & Divestments jumped 775.0% in 2023 and sank 8600.0% in 2026, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at -$12.0 million in 2022, then surged by 775.0% to $81.0 million in 2023, then slumped by 145.68% to -$37.0 million in 2024, then surged by 124.32% to $9.0 million in 2025, then plunged by 1044.44% to -$85.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered -$85.0 million, $9.0 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.